Acetyl-L-Carnitine 500 mg
Goals
$19.10 $0.31 per serving
Product analysis
Acetyl-L-Carnitine 500 mg is a clearly labelled, reasonably priced option for someone specifically seeking this form of carnitine. Evidence for a noticeable energy or focus benefit in healthy adults remains limited.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The acetyl-L-carnitine form is identified, but its quality cannot be assessed further. Disclosure alone does not establish an absorption or effectiveness advantage.
Ingredient Transparency100
The ingredient amount and form are disclosed, making the contents straightforward to compare. No relevant disclosure omission is identified.
Value For Money75
The acetyl-L-carnitine offers reasonably favourable value for the amount provided. That price advantage does not establish a noticeable energy or focus benefit.
Customer Satisfaction87
Customers give strongly positive ratings, supported by a large number of responses. They describe satisfaction and do not establish effectiveness or safety.
Product Focus57
The single ingredient keeps the formula simple, but its proposed uses reach well beyond the direct evidence. Findings in older adults with fatigue or people with neurological illness do not establish routine energy or focus benefits in healthy adults.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $0.31
- Customer rating
- 4.7 · 3,497 ratings
Goals
Impact
High effect
Acetyl L-Carnitine · 500 mg
Acetyl L-carnitine has roles related to fuel handling, but these mechanisms do not establish a routine energy boost. The saved findings recognize the 500 mg serving partially. The supplied fatigue evidence concerns adults over 70 with clinical fatigue, so it does not establish the same benefit for routine adult use or equivalence between acetyl L-carnitine hydrochloride and free acetyl L-carnitine amounts.
How this product is rated for Energy
Ingredient fit72
Acetyl L-carnitine is the sole credited active, focused on a narrow cellular-energy connection.
Goal fit
Acetyl L-carnitine is the sole credited active, focused on a narrow cellular-energy connection.
Dose adequacy
The 500 mg serving receives partial amount recognition, without establishing an effective routine fatigue dose.
Pathways40
The saved contribution concentrates on cellular energy production.
Depth
Cellular energy production is the strongest and only covered main route.
Breadth
One main route reaches the saved coverage threshold.
Evidence95
The saved evidence finding favors acetyl L-carnitine, but the supplied clinical population limits routine-use conclusions.
Evidence strength
The saved evidence finding favors acetyl L-carnitine, but the supplied clinical population limits routine-use conclusions.
Studied preparation
The preparation passes the saved check; hydrochloride mass is not independently shown equivalent to the free compound in the supplied context.
Formulation logic100
The credited ingredients do not require an additional partner, and no configured conflicts were identified.
Partner coverage
The credited ingredients can contribute without an additional required partner.
Conflicts
No configured ingredient conflict was identified; this does not establish overall safety.
Effective doses
All credited ingredients meet the saved minimum amount threshold; that threshold does not guarantee a noticeable benefit.
Impact
High effect
Acetyl L-Carnitine · 500 mg
Acetyl L-carnitine has a role in mitochondrial processes, but its supplied cognitive evidence comes from disease populations. The cited Alzheimer-disease regimen does not establish improved focus or memory in healthy adults from this serving. A larger amount is not shown here to resolve that population limitation.
How this product is rated for Cognitive Support
Ingredient fit72
Acetyl L-Carnitine contributes to the saved ingredient-fit finding. The retained amounts provide partial reference coverage.
Goal fit
The retained ingredients and the product’s other active ingredients and linked uses determine how specifically the formula addresses cognition.
Dose adequacy
The retained amounts provide partial coverage of the reference comparisons; lower exposure does not imply a proportionate cognitive benefit.
Pathways40
The strongest recorded connection is cerebral energy buffering. Coverage is concentrated in one tracked pathway.
Depth
The strongest recorded connection is cerebral energy buffering; this mapping does not establish an improvement in cognitive performance.
Breadth
Only one tracked pathway reaches the coverage threshold, leaving the recorded coverage narrow.
Evidence79
Acetyl L-Carnitine leads the saved evidence finding. The supplied limitations determine whether this concerns narrow tasks, selected populations or normal nutritional roles.
Evidence strength
Acetyl L-Carnitine leads the saved evidence finding; the supplied task, population and preparation limitations still restrict the cognitive benefits that can be described.
Studied preparation
The saved preparation comparison recognizes the retained forms; it does not establish a clinical trial of this complete product.
Formulation logic100
No required partner was missing and no configured conflict was found. The retained ingredients meet the minimum amount criterion.
Partner coverage
No missing required partner was identified for the retained ingredients. This does not establish extra benefit from combining them.
Conflicts
No configured ingredient conflict was identified; this does not establish overall safety or individual suitability.
Effective doses
All retained ingredients meet the minimum amount criterion; this is not a proven effective cognitive dose.
Impact
Moderate effect
Acetyl L-carnitine relates to fatty-acid transport and mitochondrial energy use. The 500 mg hydrochloride declaration has an indirect relationship to healthy aging; the supplied functional findings do not establish routine preservation of function in healthy adults.
How this product is rated for Longevity
Ingredient fit72
1 ingredients contribute to the saved healthy-aging assessment, with no other active ingredients reducing its focus. The contributing amounts meet only part of the saved dose benchmarks.
Goal fit
1 ingredients contribute to the saved healthy-aging assessment, with no other active ingredients reducing its focus.
Dose adequacy
The contributing amounts meet only part of the saved dose benchmarks.
Pathways11
The strongest recorded contribution concerns mitochondrial energy production. No functional area reaches the saved coverage threshold.
Depth
The strongest recorded contribution concerns mitochondrial energy production.
Breadth
No functional area reaches the saved coverage threshold.
Evidence63
Acetyl L-Carnitine provides the strongest qualifying evidence in the saved assessment; the relevant benefit remains limited to its reviewed outcome. The qualifying ingredients match the preparations used in the saved evidence review.
Evidence strength
Acetyl L-Carnitine provides the strongest qualifying evidence in the saved assessment; the relevant benefit remains limited to its reviewed outcome.
Studied preparation
The qualifying ingredients match the preparations used in the saved evidence review.
Formulation logic100
The contributing ingredients can work alone or have their required partner present. No ingredient conflicts were recorded in the saved assessment. All contributing ingredients reach the saved meaningful-dose threshold.
Partner coverage
The contributing ingredients can work alone or have their required partner present.
Conflicts
No ingredient conflicts were recorded in the saved assessment.
Effective doses
All contributing ingredients reach the saved meaningful-dose threshold.
Impact
Lower effect
Acetyl L-Carnitine · 500 mg
Impact
High effect
Acetyl L-Carnitine · 500 mg
Acetyl-L-carnitine has a role in mitochondrial and acetylcholine processes, but these mechanisms do not establish acute focus enhancement. The supplied clinical evidence concerns neurological disease and does not transfer to healthy adults seeking one-serving attention benefits. The saved result recognizes the 500 mg compound declaration, without establishing an acute clinical effect or an inferred active-content conversion.
How this product is rated for Mental Focus
Ingredient fit72
Acetyl L-Carnitine is among the recognized ingredients. The declared amounts partly match the saved comparison references; lower comparison amounts do not establish proportionate clinical effects.
Goal fit
The recognized ingredients are prominent in the formula, though links to other goals limit its exclusive focus on attention.
Dose adequacy
The declared amounts partly match the saved comparison references; lower comparison amounts do not establish proportionate clinical effects.
Pathways40
The strongest saved coverage concerns cerebral energy supply. This configured mechanism does not itself demonstrate better concentration. Only one focus pathway reaches the saved coverage threshold.
Depth
The strongest saved coverage concerns cerebral energy supply. This configured mechanism does not itself demonstrate better concentration.
Breadth
Only one focus pathway reaches the saved coverage threshold.
Evidence83
Acetyl L-Carnitine leads the saved evidence findings. The supplied population, preparation and outcome qualifications still apply.
Evidence strength
Acetyl L-Carnitine leads the saved evidence findings; study-specific limitations still restrict the benefits that can be expected.
Studied preparation
The saved result recognizes the counted preparations as studied; this does not establish equivalent effects across populations or settings.
Formulation logic100
No configured ingredient conflict was identified in the saved findings. The counted ingredients meet the saved amount threshold and have no missing required partner.
Partner coverage
The counted ingredients work independently or have their required partner; no added benefit from combining them is established.
Conflicts
No configured ingredient conflict was identified in the saved findings.
Effective doses
All counted ingredients reach the saved minimum amount threshold, which is not a proven effective dose for improved concentration.
Impact
Moderate effect
Acetyl L-Carnitine · 500 mgAcetyl L-Carnitine · 500 mg
Acetyl-L-carnitine at 500 mg relates to mitochondrial energy processes. The supplied benefit evidence comes from a neurological disease setting, so it offers little direct support for routine productivity in cognitively healthy working adults.
How this product is rated for Productivity Boost
Ingredient fit72
The relevant ingredients are focused on a small set of productivity-related roles. The assessed amounts provide a partial exposure match.
Goal fit
The relevant ingredients are focused on a small set of productivity-related roles.
Dose adequacy
The assessed amounts provide a partial exposure match.
Pathways14
The strongest assessed contribution relates to brain energy processes, with partial coverage. No assessed pathway reaches the saved substantial-coverage threshold.
Depth
The strongest assessed contribution relates to brain energy processes, with partial coverage.
Breadth
No assessed pathway reaches the saved substantial-coverage threshold.
Evidence67
Acetyl L-Carnitine provides the strongest assessed evidence at an eligible amount; the supplied population and outcome limits still apply. The ingredients assessed at eligible amounts match the preparations recognized in the saved findings.
Evidence strength
Acetyl L-Carnitine provides the strongest assessed evidence at an eligible amount; the supplied population and outcome limits still apply.
Studied preparation
The ingredients assessed at eligible amounts match the preparations recognized in the saved findings.
Formulation logic100
The assessed ingredients work alone or have their required partner. No configured ingredient conflict was identified. 1 of 1 assessed ingredients meet the saved minimum exposure threshold. Reaching it does not guarantee improved productivity.
Partner coverage
The assessed ingredients work alone or have their required partner.
Conflicts
No configured ingredient conflict was identified.
Effective doses
1 of 1 assessed ingredients meet the saved minimum exposure threshold. Reaching it does not guarantee improved productivity.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Acetyl-L-Carnitine (Acetyl-L-Carnitine Hydrochloride) | 500 mg |
A serving supplies 500 mg of acetyl L-carnitine. Its cost is about $0.32 per 500 mg of acetyl L-carnitine, among the lower costs in the comparison.
How this ingredient is rated
Active Ingredient Quality & Bioavailability94
Acetyl L-carnitine is the recorded carnitine form. The saved facts identify an HCl form; a purity or manufacturing claim is recorded but not independently verified.
ALCAR vs. Standard Carnitine Form
Acetyl L-carnitine is the recorded carnitine form.
Advanced Sourcing and Salt Specificity
The saved facts identify an HCl form; a purity or manufacturing claim is recorded but not independently verified.
Dose, Safety & Label Transparency100
A serving supplies 500 mg of acetyl L-carnitine. Its individual amount is recorded.
Clinical Dosage Efficacy
A serving supplies 500 mg of acetyl L-carnitine.
Label Transparency and Proprietary Blends
The individual amount of acetyl L-carnitine is recorded as 500 mg per serving.
Value75
The cost is about $0.32 per 500 mg of acetyl L-carnitine, among the lower costs in the comparison.
Price per 500mg Acetyl L-Carnitine
The cost is about $0.32 per 500 mg of acetyl L-carnitine, among the lower costs in the comparison.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
- Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
- Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
- Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
- Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
- A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
- Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
- Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
- The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin.
- Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
- A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.
- Metabolomic biomarkers for (R, S)-ketamine and (S)-ketamine in treatment-resistant depression and healthy controls: A systematic review.
- Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial.
- Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial.
- [Psycho-functional changes in attention and learning under the action of L-acetylcarnitine in 17 young subjects. A pilot study of its use in mental deterioration].
- Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial.
- Acetyl-L-carnitine for patients with hepatic encephalopathy.
- Low Bioavailability and High TMAO Production: Novel Insights Into Acetylcarnitine and Carnitine Metabolism.